Galmed Pharmaceuticals Ltd. buy Wells Fargo & Company
Start price
08.08.25
/
50%
€6.40
Target price
08.08.26
€56.60
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 08.08.26. The prediction end date can be changed by Wells_Fargo___Compan at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - |
| iShares Core DAX® | -1.306% | -0.778% |
| iShares Nasdaq 100 | 1.979% | -2.045% |
| iShares Nikkei 225® | 0.593% | 6.713% |
| iShares S&P 500 | 1.425% | -0.477% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target lowered by analysts at Wells Fargo & Company from $76.00 to $66.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
26.02.26
26.02.26
€87.99
26.02.27
26.02.27
-
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
07.11.25
07.11.25
€68.47
07.11.26
07.11.26
-
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
21.02.25
21.02.25
€88.72
21.02.26
21.02.26
-
22.02.26
22.02.26
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
11.12.24
11.12.24
€90.54
11.12.25
11.12.25
-
12.12.25
12.12.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
06.11.24
06.11.24
€81.94
06.11.25
06.11.25
-
07.11.25
07.11.25